1
Treatment of Mature B-cell Lymphoma/Leukaemia
Condition(s):B-Cell LymphomaLast Updated:March 28, 2012Completed
Half Cyclophosphamide: 107 Clinical Trials, Page 1 of 11
Hide Studies Not Open or Pending
2
Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
Condition(s):Lupus NephritisLast Updated:March 6, 2017Completed
3
Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis
Condition(s):To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis PatientsLast Updated:June 28, 2017Completed
4
Low Dose Cyclophosphamide Treats Genital Warts
Condition(s):Genital WartLast Updated:November 25, 2009Completed
5
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
Condition(s):Hematologic MalignancyLast Updated:September 5, 2023Active, not recruiting
6
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
Condition(s):Breast Cancer; Chemotherapeutic ToxicityLast Updated:April 14, 2022Recruiting
7
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin’s Lymphoma
Condition(s):Non-Hodgkin’s LymphomaLast Updated:September 25, 2018Terminated
8
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
Condition(s):Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Non-hodgkin Lymphoma; Chronic Lymphocytic LeukemiaLast Updated:April 23, 2021Unknown status
9
Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition(s):Leukemia, Myeloid, AcuteLast Updated:October 12, 2018Terminated
10
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
Condition(s):Multiple MyelomaLast Updated:August 17, 2018Unknown status